Clinical Oncology - Issue 2/2026
Editorial
Review
86
Treatment of Castleman disease from the perspective of the year 2026
Z. Adam, Z. Řehák, I. Boichuk, T. Horváth, Z. Adamová, M. Štork, L. Pour
99
Ewing sarcoma – current diagnostic and therapeutic approaches
A. Nohejlová Medková, P. Pacas, K. Kopečková
105
Case Report
112
117
Second recurrence of breast cancer 36 years after initial surgery and 18 years after the first recurrence – an extremely rare case
Y. Maezawa, T. Terada, H. Kobayashi, G. Ohara, T. Saito, N. Takayashiki, H. Satoh
Oncology in Images
122
FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?
Z. Řehák, M. Palácová, S. Soboličová, P. Fabian
Letter to Editor
126
Cancer patients admitted to intensive care unit
M. Uchiyama, Y. Maezawa, H. Satoh, R. Hasegawa
NUVR Reports
Clinical Oncology
2026 Issue 2
Most read in this issue
- Treatment of Castleman disease from the perspective of the year 2026
- FDG-PET/CT: metabolically active solitary lesion in the gluteal region subcutaneously in a patient with breast cancer – granuloma or metastasis?
- Ewing sarcoma – current diagnostic and therapeutic approaches
- Circulating tumor DNA as a biomarker for the prediction of minimal residual disease and the individualization of adjuvant therapy in colorectal cancer – a review of current evidence and perspectives